Research
Interests
Dr.
Fried is studying patients with chronic hepatitis C in order to
investigate the effects of alcohol consumption on disease progression.
The underlying hypothesis is that alcohol accelerates the rate
of liver fibrosis in hepatitis-infected livers through multiple
mechanisms that can be individually measured in the laboratory.
Studies will determine if chronic alcohol intake enhances the
activation of Kupffer cells that increase inflammation of the
liver.
Fried
is planning a collaboration with David Brenner, M.D., investigator
with the Center for Alcohol Studies, and with Bill Renn, director
of the Alcohol and Substance Abuse Treatment Program to determine
if the progression of liver disease in hepatitis C can be reversed
if patients receive counseling and treatment to promote abstinence
from alcohol. His studies provide new hope in the treatment of
alcohol-related diseases.
News
Dr.
Michael W. Fried was recently inducted into the American
Society of Clinical Investigation (ASCI) at the organization's
annual meeting, April 16-18, 2004, in Chicago, Illinois. The ASCI
is an honor society of physician-scientists, those who translate
findings in the laboratory to the advancement of clinical practice.
Founded in 1908, the Society is home to more than 2,700 members
who are in the upper ranks of academic medicine and corporate
healthcare.
Center Line Articles
Selected
Publications
Click
for list of publications from PubMed
Russo
MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver
transplantation for acute liver failure from drug induced liver
injury in the United States. Liver Transpl. 2004 Aug;10(8):1018-23.
Russo
MW, Galanko J, Beavers K, Fried MW, Shrestha R. Patient
and graft survival in hepatitis C recipients after adult living
donor liver transplantation in the United States. Liver
Transpl. 2004 Mar;10(3):340-6.
Fried
MW. The
NIH roadmap for medical research: bypassing detours. Gastroenterology.
2004 Feb;126(2):392.
Russo
MW, Fried MW. Guidelines
for stopping therapy in chronic hepatitis C. Curr Gastroenterol
Rep. 2004 Feb;6(1):17-21.
Zeuzem
S, Heathcote EJ, Shiffman ML, Wright TL, Bain VG, Sherman M, Feinman
SV, Fried MW, Rasenack J, Sarrazin C, Jensen DM, Lin A, Hoffman
JH, Sedarati F. Twelve
weeks of follow-up is sufficient for the determination of sustained
virologic response in patients treated with interferon alpha for
chronic hepatitis C. J Hepatol. 2003 Jul;39(1):106-11.
Ziegler
TR, Fernandez-Estivariz C, Gu LH, Fried MW, Leader LM. Severe
villus atrophy and chronic malabsorption induced by azathioprine.
Gastroenterology. 2003 Jun;124(7):1950-7.
Russo
MW, Fried MW. Side
effects of therapy for chronic hepatitis C. Gastroenterology.
2003 May;124(6):1711-9. Review.
Morgan
TR, Brenner D, Everhart J, French SW, Fried MW, Gretch DR, Koziel
MJ, McClain CJ, Peters MG, Weinman SA, Lucas DL. Hepatitis
C and alcohol: fundamental and translational research directions.
Alcohol Clin Exp Res. 2003 Apr;27(4):726-31.
Theodore
D, Shiffman ML, Sterling RK, Bruno CJ, Weinstein J, Crippin JS,
Garcia G, Wright TL, Conjeevaram H, Reddy RK, Nolte FS, Fried
MW. Intensive
interferon therapy does not increase virological response rates
in African Americans with chronic hepatitis C. Dig Dis
Sci. 2003 Jan;48(1):140-5.
Fried MW.
Side
effects of therapy of hepatitis C and their management. Hepatology.
2002 Nov;36(5 Suppl):S237-44.
Jackson EW,
Zacks S, Zinn S, Ryan J, Johnson MW, Gerber DA, Andreoni K, Fair
JH, Shrestha R, Fried MW. Delayed
neuropsychologic dysfunction after liver transplantation for acute
liver failure: A matched, case-controlled study. Liver
Transpl. 2002 Oct;8(10):932-6.
Fried MW,
Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger
D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu
J. Peginterferon
alfa-2a plus ribavirin for chronic hepatitis C virus infection.
N Engl J Med. 2002 Sep 26;347(13):975-82.
Fried MW.
Advances
in therapy for chronic hepatitis C. Clin Liver Dis.
2001 Nov;5(4):1009-23. Review.
Zacks SL,
Fried MW. Hepatitis
B and C and renal failure. Infect Dis Clin North Am.
2001 Sep;15(3):877-99. Review.
Back
to Top
|